Rituximab in connective tissue disease–associated interstitial lung disease
2019
Introduction/objectives
To evaluate rituximab (RTX) effectiveness and safety in patients with interstitial lung disease (ILD) related to connective tissue diseases (CTD).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
19
Citations
NaN
KQI